Skip to main content
Log in

Role of PPARγ in COX-2 Activation in Mycobacterial Pulmonary Inflammation

  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

Preliminary studies show that intranasal (i.n.) administration of BCG in mice induces M1 activation of alveolar macrophages (M∅) that increase TNF-α production and cyclooxygenase-2 (COX-2) expression but reduce constitutive peroxisome proliferator-activated receptor gamma (PPARγ) expression. However, COX-2 is catalytically inactive for prostaglandin E2 release, unlike COX-2 that is active in M1 activation in vitro by BCG. In this study, we determined the role of PPARγ for BCG-induced M1 activation in vivo and in vitro. We found that treatment of mice with GW9662, a PPARγ antagonist, prior to i.n. BCG, partially restored PPARγ expression, and decreased TNF-α production and COX-2 expression. But COX-2 was still inactive. The decreased effects on TNF-α and COX-2 were also observed when alveolar M∅ were treated in vitro with GW9662/BCG, but COX-2 was still active. Our results indicate that PPARγ upregulates M1 activation of alveolar M∅, but inactive COX-2 formation is independent of PPARγ in mycobacterial pulmonary inflammation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Shibata, Y., R.A. Henriksen, I. Honda, R.M. Nakamura, and Q.N. Myrvik. 2005. Splenic PGE2-releasing macrophages regulate Th1 and Th2 immune responses in mice treated with heat-killed BCG. Journal of Leukocyte Biology 78: 1281–1290.

    Article  PubMed  CAS  Google Scholar 

  2. Shibata, Y., H. Ohata, M. Yamashita, S. Tsuji, J.F. Bradfield, A. Nishiyama, R.A. Henriksen, and Q.N. Myrvik. 2007. Immunologic response enhances atherosclerosis-type 1 helper T cell (Th1)-to-type 2 helper T cell (Th2) shift and calcified atherosclerosis in Bacillus Calmette-Guerin (BCG)-treated apolipoprotein E-knockout (apo E(−/−)) mice. Translational Research 149: 62–69.

    Article  PubMed  CAS  Google Scholar 

  3. Shibata, Y., J. Gabbard, M. Yamashita, S. Tsuji, M. Smith, A. Nishiyama, R.A. Henriksen, and Q.N. Myrvik. 2006. Heat-killed BCG induces biphasic cyclooxygenase 2+ splenic macrophage formation—role of IL-10 and bone marrow precursors. Journal of Leukocyte Biology 80: 590–598.

    Article  PubMed  CAS  Google Scholar 

  4. Shinohara, T., T. Pantuso, S. Shinohara, M. Kogiso, Q.N. Myrvik, R.A. Henriksen, and Y. Shibata. 2009. Persistent inactivation of macrophage cyclooxygenase-2 in mycobacterial pulmonary inflammation. American Journal of Respiratory Cell and Molecular Biology 41: 146–154.

    Article  PubMed  CAS  Google Scholar 

  5. Yamashita, M., T. Shinohara, S. Tsuji, Q.N. Myrvik, A. Nishiyama, R.A. Henriksen, and Y. Shibata. 2007. Catalytically inactive cyclooxygenase 2 and absence of prostaglandin E2 biosynthesis in murine peritoneal macrophages following in vivo phagocytosis of heat-killed Mycobacterium bovis bacillus Calmette-Guerin. The Journal of Immunology 179: 7072–7078.

    PubMed  CAS  Google Scholar 

  6. Yamashita, M., S. Tsuji, A. Nishiyama, Q.N. Myrvik, R.A. Henriksen, and Y. Shibata. 2007. Differential subcellular localization of COX-2 in macrophages phagocytosing heat-killed Mycobacterium bovis BCG. American Journal of Physiology. Cell Physiology 293: C184–C190.

    Article  PubMed  CAS  Google Scholar 

  7. Rangel Moreno, J., I. Estrada Garcia, M. De La Luz Garcia, D.A. Hernandez, R.M. Leon, and R. Hernandez Pando. 2002. The role of prostaglandin E2 in the immunopathogenesis of experimental pulmonary tuberculosis. Immunology 106: 257–266.

    Article  PubMed  Google Scholar 

  8. van der Pouw Kraan, T.C., L.C. Boeije, R.J. Smeenk, J. Wijdenes, and L.A. Aarden. 1995. Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. The Journal of Experimental Medicine 181: 775–779.

    Article  PubMed  Google Scholar 

  9. Harbrecht, B.G., Y.M. Kim, E.A. Wirant, R.L. Simmons, and T.R. Billiar. 1997. Timing of prostaglandin exposure is critical for the inhibition of LPS- or IFN-gamma-induced macrophage NO synthesis by PGE2. Journal of Leukocyte Biology 61: 712–720.

    PubMed  CAS  Google Scholar 

  10. Pillinger, M.H., M.R. Philips, A. Feoktistov, and G. Weissmann. 1995. Crosstalk in signal transduction via EP receptors: prostaglandin E1 inhibits chemoattractant-induced mitogen-activated protein kinase activity in human neutrophils. Advances in Prostaglandin, Thromboxane, and Leukotriene Research 23: 311–316.

    PubMed  CAS  Google Scholar 

  11. Shinomiya, S., H. Naraba, A. Ueno, I. Utsunomiya, T. Maruyama, S. Ohuchida, F. Ushikubi, K. Yuki, S. Narumiya, Y. Sugimoto, A. Ichikawa, and S. Oh-ishi. 2001. Regulation of TNFalpha and interleukin-10 production by prostaglandins I(2) and E(2): studies with prostaglandin receptor-deficient mice and prostaglandin E-receptor subtype-selective synthetic agonists. Biochemical Pharmacology 61: 1153–1160.

    Article  PubMed  CAS  Google Scholar 

  12. Sheibanie, A.F., I. Tadmori, H. Jing, E. Vassiliou, and D. Ganea. 2004. Prostaglandin E2 induces IL-23 production in bone marrow-derived dendritic cells. The FASEB Journal 18: 1318–1320.

    CAS  Google Scholar 

  13. Pavlovic, S., B. Du, K. Sakamoto, K.M. Khan, C. Natarajan, R.M. Breyer, A.J. Dannenberg, and D.J. Falcone. 2006. Targeting prostaglandin E2 receptors as an alternative strategy to block cyclooxygenase-2-dependent extracellular matrix-induced matrix metalloproteinase-9 expression by macrophages. The Journal of Biological Chemistry 281: 3321–3328.

    Article  PubMed  CAS  Google Scholar 

  14. Rodriguez, A., A. Tjarnlund, J. Ivanji, M. Singh, I. Garcia, A. Williams, P.D. Marsh, M. Troye-Blomberg, and C. Fernandez. 2005. Role of IgA in the defense against respiratory infections IgA deficient mice exhibited increased susceptibility to intranasal infection with Mycobacterium bovis BCG. Vaccine 23: 2565–2572.

    Article  PubMed  CAS  Google Scholar 

  15. Chen, M., M. Divangahi, H. Gan, D.S. Shin, S. Hong, D.M. Lee, C.N. Serhan, S.M. Behar, and H.G. Remold. 2008. Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death. The Journal of Experimental Medicine 205: 2791–2801.

    Article  PubMed  CAS  Google Scholar 

  16. Haile, M., U. Schroder, B. Hamasur, A. Pawlowski, T. Jaxmar, G. Kallenius, and S.B. Svenson. 2004. Immunization with heat-killed Mycobacterium bovis bacille Calmette-Guerin (BCG) in Eurocine L3 adjuvant protects against tuberculosis. Vaccine 22: 1498–1508.

    Article  PubMed  CAS  Google Scholar 

  17. Myrvik, Q.N., E.S. Leake, and S. Oshima. 1962. A study of macrophages and epitheloid-like cells from granulomatous (BCG-induced) lungs of rabbits. The Journal of Immunology 89: 745–751.

    PubMed  CAS  Google Scholar 

  18. Reddy, R.C., V.G. Keshamouni, S.H. Jaigirdar, X. Zeng, T. Leff, V.J. Thannickal, and T.J. Standiford. 2004. Deactivation of murine alveolar macrophages by peroxisome proliferator-activated receptor-gamma ligands. American Journal of Physiology. Lung Cellular and Molecular Physiology 286: L613–L619.

    Article  PubMed  CAS  Google Scholar 

  19. Asada, K., S. Sasaki, T. Suda, K. Chida, and H. Nakamura. 2004. Antiinflammatory roles of peroxisome proliferator-activated receptor gamma in human alveolar macrophages. American Journal of Respiratory and Critical Care Medicine 169: 195–200.

    Article  PubMed  Google Scholar 

  20. Chinetti, G., S. Griglio, M. Antonucci, I.P. Torra, P. Delerive, Z. Majd, J.C. Fruchart, J. Chapman, J. Najib, and B. Staels. 1998. Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages. The Journal of Biological Chemistry 273: 25573–25580.

    Article  PubMed  CAS  Google Scholar 

  21. Weber, S.M., K.T. Chambers, K.G. Bensch, A.L. Scarim, and J.A. Corbett. 2004. PPARgamma ligands induce ER stress in pancreatic beta-cells: ER stress activation results in attenuation of cytokine signaling. American Journal of Physiology. Endocrinology and Metabolism 287: E1171–E1177.

    Article  PubMed  CAS  Google Scholar 

  22. Lee, Y.J., H.N. Suh, and H.J. Han. 2009. Effect of BSA-induced ER stress on SGLT protein expression levels and alpha-MG uptake in renal proximal tubule cells. American Journal of Physiology. Renal Physiology 296: F1405–F1416.

    Article  PubMed  CAS  Google Scholar 

  23. Ricote, M., A.C. Li, T.M. Willson, C.J. Kelly, and C.K. Glass. 1998. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391: 79–82.

    Article  PubMed  CAS  Google Scholar 

  24. Malur, A., A.J. McCoy, S. Arce, B.P. Barna, M.S. Kavuru, A.G. Malur, and M.J. Thomassen. 2009. Deletion of PPAR gamma in alveolar macrophages is associated with a Th-1 pulmonary inflammatory response. The Journal of Immunology 182: 5816–5822.

    Article  PubMed  CAS  Google Scholar 

  25. Ayoub, S.S., R.M. Botting, A.N. Joshi, M.P. Seed, and P.R. Colville-Nash. 2009. Activation of macrophage peroxisome proliferator-activated receptor-gamma by diclofenac results in the induction of cyclooxygenase-2 protein and the synthesis of anti-inflammatory cytokines. Molecular and Cellular Biochemistry 327: 101–110.

    Article  PubMed  CAS  Google Scholar 

  26. Jiang, C., A.T. Ting, and B. Seed. 1998. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391: 82–86.

    Article  PubMed  CAS  Google Scholar 

  27. Almeida, P.E., A.R. Silva, C.M. Maya-Monteiro, D. Torocsik, H. D'Avila, B. Dezso, K.G. Magalhaes, H.C. Castro-Faria-Neto, L. Nagy, and P.T. Bozza. 2009. Mycobacterium bovis bacillus Calmette-Guerin infection induces TLR2-dependent peroxisome proliferator-activated receptor gamma expression and activation: functions in inflammation, lipid metabolism, and pathogenesis. The Journal of Immunology 183: 1337–1345.

    Article  PubMed  CAS  Google Scholar 

  28. Collino, M., N.S. Patel, K.M. Lawrence, M. Collin, D.S. Latchman, M.M. Yaqoob, and C. Thiemermann. 2005. The selective PPARgamma antagonist GW9662 reverses the protection of LPS in a model of renal ischemia-reperfusion. Kidney International 68: 529–536.

    Article  PubMed  CAS  Google Scholar 

  29. Cuzzocrea, S., B. Pisano, L. Dugo, A. Ianaro, N.S. Patel, R. Di Paola, T. Genovese, P.K. Chatterjee, F. Fulia, E. Cuzzocrea, M. Di Rosa, A.P. Caputi, and C. Thiemermann. 2004. Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces the development of nonseptic shock induced by zymosan in mice. Critical Care Medicine 32: 457–466.

    Article  PubMed  CAS  Google Scholar 

  30. Hounoki, H., E. Sugiyama, S.G. Mohamed, K. Shinoda, H. Taki, H.O. Abdel-Aziz, M. Maruyama, M. Kobayashi, and T. Miyahara. 2008. Activation of peroxisome proliferator-activated receptor gamma inhibits TNF-alpha-mediated osteoclast differentiation in human peripheral monocytes in part via suppression of monocyte chemoattractant protein-1 expression. Bone 42: 765–774.

    Article  PubMed  CAS  Google Scholar 

  31. Floyd, Z.E., and J.M. Stephens. 2002. Interferon-gamma-mediated activation and ubiquitin-proteasome-dependent degradation of PPARgamma in adipocytes. The Journal of Biological Chemistry 277: 4062–4068.

    Article  PubMed  CAS  Google Scholar 

  32. He, F., J.A. Doucet, and J.M. Stephens. 2008. Caspase-mediated degradation of PPARgamma proteins in adipocytes. Obesity (Silver Spring) 16: 1735–1741.

    Article  CAS  Google Scholar 

  33. Leesnitzer, L.M., D.J. Parks, R.K. Bledsoe, J.E. Cobb, J.L. Collins, T.G. Consler, R.G. Davis, E.A. Hull-Ryde, J.M. Lenhard, L. Patel, K.D. Plunket, J.L. Shenk, J.B. Stimmel, C. Therapontos, T.M. Willson, and S.G. Blanchard. 2002. Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662. Biochemistry 41: 6640–6650.

    Article  PubMed  CAS  Google Scholar 

  34. Majai, G., Z. Sarang, K. Csomos, G. Zahuczky, and L. Fesus. 2007. PPARgamma-dependent regulation of human macrophages in phagocytosis of apoptotic cells. European Journal of Immunology 37: 1343–1354.

    Article  PubMed  CAS  Google Scholar 

  35. Liu, D., B.X. Zeng, and Y. Shang. 2006. Decreased expression of peroxisome proliferator-activated receptor gamma in endotoxin-induced acute lung injury. Physiological Research 55: 291–299.

    PubMed  CAS  Google Scholar 

  36. Culver, D.A., B.P. Barna, B. Raychaudhuri, T.L. Bonfield, S. Abraham, A. Malur, C.F. Farver, M.S. Kavuru, and M.J. Thomassen. 2004. Peroxisome proliferator-activated receptor gamma activity is deficient in alveolar macrophages in pulmonary sarcoidosis. American Journal of Respiratory Cell and Molecular Biology 30: 1–5.

    Article  PubMed  CAS  Google Scholar 

  37. Woerly, G., K. Honda, M. Loyens, J.P. Papin, J. Auwerx, B. Staels, M. Capron, and D. Dombrowicz. 2003. Peroxisome proliferator-activated receptors alpha and gamma down-regulate allergic inflammation and eosinophil activation. The Journal of Experimental Medicine 198: 411–421.

    Article  PubMed  CAS  Google Scholar 

  38. Barna, B.P., D.A. Culver, S. Abraham, A. Malur, T.L. Bonfield, N. John, C.F. Farver, J.A. Drazba, B. Raychaudhuri, M.S. Kavuru, and M.J. Thomassen. 2006. Depressed peroxisome proliferator-activated receptor gamma (PPargamma) is indicative of severe pulmonary sarcoidosis: possible involvement of interferon gamma (IFN-gamma). Sarcoidosis, Vasculitis, and Diffuse Lung Diseases 23: 93–100.

    PubMed  Google Scholar 

  39. Bonfield, T.L., C.F. Farver, B.P. Barna, A. Malur, S. Abraham, B. Raychaudhuri, M.S. Kavuru, and M.J. Thomassen. 2003. Peroxisome proliferator-activated receptor-gamma is deficient in alveolar macrophages from patients with alveolar proteinosis. American Journal of Respiratory Cell and Molecular Biology 29: 677–682.

    Article  PubMed  CAS  Google Scholar 

  40. Standiford, T.J., V.G. Keshamouni, and R.C. Reddy. 2005. Peroxisome proliferator-activated receptor-{gamma} as a regulator of lung inflammation and repair. Proceedings of the American Thoracic Society 2: 226–231.

    Article  PubMed  CAS  Google Scholar 

  41. Wada, M., T.L. Saunders, J. Morrow, G.L. Milne, K.P. Walker, S.K. Dey, T.G. Brock, M.R. Opp, D.M. Aronoff, and W.L. Smith. 2009. Two pathways for cyclooxygenase-2 protein degradation in vivo. The Journal of Biological Chemistry 284: 30742–30753.

    Article  PubMed  CAS  Google Scholar 

  42. Singh, M., P. Chaudhry, S. Parent, and E. Asselin. 2012. Ubiquitin-proteasomal degradation of COX-2 in TGF-beta stimulated human endometrial cells is mediated through endoplasmic reticulum mannosidase I. Endocrinology 153: 426–437.

    Article  PubMed  CAS  Google Scholar 

  43. Tabas, I. 2010. The role of endoplasmic reticulum stress in the progression of atherosclerosis. Circulation Research 107: 839–850.

    Article  PubMed  CAS  Google Scholar 

  44. Antonicelli, F., D. Brown, M. Parmentier, E.M. Drost, N. Hirani, I. Rahman, K. Donaldson, and W. MacNee. 2004. Regulation of LPS-mediated inflammation in vivo and in vitro by the thiol antioxidant Nacystelyn. American Journal of Physiology. Lung Cellular and Molecular Physiology 286: L1319–L1327.

    Article  PubMed  CAS  Google Scholar 

  45. Shibata, Y., A.P. Bautista, S.N. Pennington, J.L. Humes, and A. Volkman. 1987. Eicosanoid production by peritoneal and splenic macrophages in mice depleted of bone marrow by 89Sr. The American Journal of Pathology 127: 75–82.

    PubMed  CAS  Google Scholar 

  46. Carlos, D., D.A. de Souza Junior, L. de Paula, M.C. Jamur, C. Oliver, S.G. Ramos, C.L. Silva, and L.H. Faccioli. 2007. Mast cells modulate pulmonary acute inflammation and host defense in a murine model of tuberculosis. The Journal of Infectious Diseases 196: 1361–1368.

    Article  PubMed  CAS  Google Scholar 

  47. Moskovitz, J., N.A. Jenkins, D.J. Gilbert, N.G. Copeland, F. Jursky, H. Weissbach, and N. Brot. 1996. Chromosomal localization of the mammalian peptide-methionine sulfoxide reductase gene and its differential expression in various tissues. Proceedings of the National Academy of Sciences of the United States of America 93: 3205–3208.

    Article  PubMed  CAS  Google Scholar 

  48. Hiratsuka, S., O. Minowa, J. Kuno, T. Noda, and M. Shibuya. 1998. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proceedings of the National Academy of Sciences of the United States of America 95: 9349–9354.

    Article  PubMed  CAS  Google Scholar 

  49. Kogiso, M., A. Nishiyama, T. Shinohara, M. Nakamura, E. Mizoguchi, Y. Misawa, E. Guinet, M. Nouri-Shirazi, C.K. Dorey, R.A. Henriksen, and Y. Shibata. 2011. Chitin particles induce size-dependent but carbohydrate-independent innate eosinophilia. Journal of Leukocyte Biology 90: 167–176.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by NIH RO1 HL71711, DOD DAMD 17-03-1-0004, Bankhead-Coley Cancer Research Program 06BS-04-9615, and the Charles E. Schmidt Biomedical Foundation (YS). The authors thank Dr. Ikuro Honda, Japan BCG Laboratory, Tokyo, for providing BCG for this study. Authors wish to thank Traci Pantuso for her technical assistance. This paper is dedicated to the memory of Ruth Ann Henriksen (Deceased April 28, 2011) whose lively intellectual exchanges will be missed.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yoshimi Shibata.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kogiso, M., Shinohara, T., Dorey, C.K. et al. Role of PPARγ in COX-2 Activation in Mycobacterial Pulmonary Inflammation. Inflammation 35, 1685–1695 (2012). https://doi.org/10.1007/s10753-012-9486-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10753-012-9486-x

KEY WORDS

Navigation